GPW
TMO icon

Genesis Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Genesis Private Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Sell
873
-29
-3% -$13.9K 0.12% 96
2026
Q1 		$443K Sell
902
-21
-2% -$11.4K 0.14% 92
2025
Q4 		$535K Buy
923
+455
+97% +$257K 0.17% 84
2025
Q3 		$227K Buy
+468
New +$218K 0.1% 134

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Genesis Private Wealth's TMO Position: Q2 2026 in Review

Genesis Private Wealth reduced its Thermo Fisher Scientific (TMO) stake by 3.2% in Q2 2026, selling an estimated $13.9K and leaving 873 shares worth $438K. The position accounts for 0.12% of the portfolio, ranked #96.

Genesis Private Wealth first reported a position in TMO in Q3 2025 and has held it in 4 quarters since. The position peaked at $535K in Q4 2025. 567 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Genesis Private Wealth held 873 shares of Thermo Fisher Scientific worth $438K as of Q2 2026.
  • Genesis Private Wealth sold 29 Thermo Fisher Scientific shares in Q2 2026, an estimated $13.9K.
  • Thermo Fisher Scientific made up 0.12% of Genesis Private Wealth's portfolio in Q2 2026, its #96 holding.
  • Genesis Private Wealth first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 4 quarters since.
  • Genesis Private Wealth's Thermo Fisher Scientific position peaked at $535K in Q4 2025.
  • 567 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Genesis Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.